(Q53667899)

17 May 2018

title

Evolution of the response to levodopa during the first 4 years of therapy. (English)

1 reference

17 May 2018

1 reference

1

John G Nutt

1 reference

17 May 2018

Julie H Carter

2

1 reference

17 May 2018

Eric S Lea

series ordinal

3

1 reference

17 May 2018

Gary J Sexton

series ordinal

4

1 reference

17 May 2018

publication date

1 June 2002

1 reference

17 May 2018

published in

Annals of Neurology

1 reference

17 May 2018

volume

51

1 reference

17 May 2018

issue

6

1 reference

17 May 2018

page(s)

686-693

1 reference

17 May 2018

Success and problems of long-term levodopa therapy in Parkinson's disease

cites work

1 reference

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years

21 January 2018

1 reference

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

21 January 2018

1 reference

Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuations

21 January 2018

1 reference

Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon

21 January 2018

1 reference

Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.

21 January 2018

1 reference

Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning

21 January 2018

1 reference

Comparison of Sensitization to Ambulation-increasing Effects of Cocaine and Methamphetamine after Repeated Administration in Mice

21 January 2018

1 reference

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

21 January 2018

1 reference

Long-term follow-up of levodopa responsiveness in generalized dystonia

21 January 2018

1 reference

Response to levodopa treatment in dopa-responsive dystonia

21 January 2018

1 reference

Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life.

21 January 2018

1 reference

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

21 January 2018

1 reference

Interactions between deep brain stimulation and levodopa in Parkinson's disease

21 January 2018

1 reference

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

21 January 2018

1 reference

Short- and long-duration responses to levodopa during the first year of levodopa therapy.

21 January 2018

1 reference

Evolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years.

21 January 2018

1 reference

Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease

21 January 2018

1 reference

Loss of long-duration response to levodopa over time in PD: implications for wearing-off

21 January 2018

1 reference

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I

21 January 2018

1 reference

Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon

21 January 2018

1 reference

Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease

21 January 2018

1 reference

Enhanced response to low doses of levodopa after withdrawal from chronic treatment

21 January 2018

1 reference

Long-duration response to levodopa

21 January 2018

1 reference

Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease

21 January 2018

1 reference

Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease

21 January 2018

1 reference

Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity

21 January 2018

1 reference

The Long-Duration Action of Levodopa May Be Due to a Postsynaptic Effect

21 January 2018

1 reference

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease

21 January 2018

1 reference

The subacute levodopa test for evaluating long-duration response in parkinson's disease

21 January 2018

1 reference

Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease

21 January 2018

1 reference

Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up study

21 January 2018

1 reference

Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease

21 January 2018

1 reference

Oral pulse levodopa therapy in mild Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10189

1 reference

17 May 2018

PubMed ID

12112073

1 reference

17 May 2018